Literature DB >> 4796513

Long-lasting remission of Behcet's disease after chlorambucil therapy.

M I Abdalla, N el-D Bahoat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4796513      PMCID： PMC1215137          DOI： 10.1136/bjo.57.9.706

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  13 in total

1.  VIRUS AETIOLOGY OF BEH CET'S SYNDROME.

Authors:  A MORTADA; I Z IMAM
Journal:  Br J Ophthalmol       Date:  1964-05       Impact factor: 4.638

2.  Neurologic aspects of Behcet's disease. Case report and review of the literature.

Authors:  D L SCHOTLAND; S M WOLF; H H WHITE; H V DUBIN
Journal:  Am J Med       Date:  1963-04       Impact factor: 4.965

3.  Behcet's syndrome complicated by intracranial thrombophlebitis.

Authors:  H C MASHETER
Journal:  Proc R Soc Med       Date:  1959-12

4.  Clinical Studies on Behçet's Syndrome.

Authors:  Y Oshima; T Shimizu; R Yokohari; T Matsumoto; K Kano; T Kagami; H Nagaya
Journal:  Ann Rheum Dis       Date:  1963-01       Impact factor: 19.103

5.  Immunosuppressive therapy of ocular inflammatory diseases.

Authors:  V G Wong
Journal:  Arch Ophthalmol       Date:  1969-05

6.  Treatment of exudative diabetic retinopathy with atromid-S.

Authors:  A J Houtsmuller
Journal:  Ophthalmologica       Date:  1968       Impact factor: 3.250

7.  Treatment of Behçet's disease with chlorambucil.

Authors:  J G Mamo; S A Azzam
Journal:  Arch Ophthalmol       Date:  1970-10

8.  Immunological studies on Behçet's syndrome.

Authors:  T Shimizu; Y Katsuta; Y Oshima
Journal:  Ann Rheum Dis       Date:  1965-09       Impact factor: 19.103

9.  Behcet's disease with retinal vascular lesions.

Authors:  R B Smith; I A Prior; D Sturman
Journal:  Br Med J       Date:  1967-04-22

10.  Suppression of allergic uveitis by 6-mercaptopurine.

Authors:  E WIROSTKO; S P HALBERT
Journal:  J Exp Med       Date:  1962-11-01       Impact factor: 14.307
View more
  12 in total

1.  Immunosuppressives in uveitis. A preliminary report of experience with chlorambucil.

Authors:  W J Dinning; E S Perkins
Journal:  Br J Ophthalmol       Date:  1975-08       Impact factor: 4.638

2.  Behçet's Disease.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-09       Impact factor: 3.598

3.  Diagnostic dilemma between intestinal Behçet disease and inflammatory bowel disease with pyoderma gangrenosum.

Authors:  Cem Evereklioglu
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

4.  High-dose short-term chlorambucil for intractable sympathetic ophthalmia and Behçet's disease.

Authors:  H H Tessler; T Jennings
Journal:  Br J Ophthalmol       Date:  1990-06       Impact factor: 4.638

5.  Treatment of Behcet's disease with chlorambucil.

Authors:  D Tricoulis
Journal:  Br J Ophthalmol       Date:  1976-01       Impact factor: 4.638

6.  Electrophysiological and MRI evaluation of neurological involvement in Behçet's disease.

Authors:  C Besana; G Comi; A Del Maschio; L Praderio; A Vergani; S Medaglini; V Martinelli; F Triulzi; T Locatelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

Review 7.  Recent advances in the study of uveitis.

Authors:  E S Perkins
Journal:  Br J Ophthalmol       Date:  1974-04       Impact factor: 4.638

8.  Behçet's syndrome: treatment with chlorambucil.

Authors:  J H Elliott; W H Ballinger
Journal:  Trans Am Ophthalmol Soc       Date:  1984

Review 9.  Pharmacotherapy for Behcet's syndrome.

Authors:  A Saenz; M Ausejo; B Shea; G Wells; V Welch; P Tugwell
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 10.  Clinical use of immunosuppressive drugs: part I.

Authors:  N L Gerber; A D Steinberg
Journal:  Drugs       Date:  1976       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.